Oscar Health (OSCR) Set to Announce Earnings on Thursday

Oscar Health (NYSE:OSCR) will announce its earnings results before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The firm had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm’s revenue was up 44.6% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.07) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Trading Up 7.0 %

NYSE:OSCR opened at $17.04 on Thursday. Oscar Health has a 12-month low of $4.84 and a 12-month high of $23.79. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The stock’s 50 day simple moving average is $18.74 and its 200-day simple moving average is $18.37. The firm has a market cap of $4.12 billion, a P/E ratio of -131.08, a PEG ratio of 32.07 and a beta of 1.62.

Insider Buying and Selling

In related news, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the sale, the chief financial officer now owns 884,213 shares in the company, valued at $15,906,991.87. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, EVP Ranmali Bopitiya sold 36,175 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $650,788.25. Following the sale, the executive vice president now directly owns 251,885 shares in the company, valued at $4,531,411.15. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares in the company, valued at approximately $15,906,991.87. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 169,569 shares of company stock valued at $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on OSCR. UBS Group initiated coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.00.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.